MedCity News
FEBRUARY 23, 2025
Compounded GLP-1s have become more widespread, but are they safe? Some argue that compounding is nothing new, while others believe these drugs are dangerous for patients. The post Hims & Hers vs. Novo Nordisk: Are Compounded GLP-1s Safe? appeared first on MedCity News.
PharmaTech
FEBRUARY 23, 2025
Webinar Date/Time: Thu, Mar 13, 2025 11:00 AM EDT
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
FEBRUARY 23, 2025
Currently, the agent is undergoing evaluation in a phase 2 clinical trial to determine its safety and efficacy.
PharmaTech
FEBRUARY 23, 2025
Webinar Date/Time: Webinar Date/Time: Thu, Mar 27, 2025 10:00 AM EDT
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
FEBRUARY 23, 2025
The distinction between value-based care and value-based payment isn’t merely semantic it represents a crucial fork in the road for healthcare delivery. As AI and other technologies become more prevalent in healthcare, we must ensure they’re deployed in service of improving patient care rather than merely optimizing revenue. The post The Dark Side of AI in Medicare Advantage: When Value-Based Payment Eclipses Value-Based Care appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
FEBRUARY 23, 2025
Healthcare AI is developing at a rapid rate, and the industrys attitude on how to best regulate and deploy this technology is evolving every day, according to leaders attending this years ViVE conference. The post The Hardest Thing Is Separating the Wheat from the Chaff: 5 Leaders on the State of Healthcare AI appeared first on MedCity News.
MedCity News
FEBRUARY 23, 2025
BridgeBio Pharmas approval of Beyonttra comes three months after the drug landed FDA approval for cardiomyopathy caused by transthyretin amyloidosis. Our recap of recent regulatory news also spans approvals in cancer, immunology, vaccines, and more. The post On Heels of FDA Nod, BridgeBios Rival to Blockbuster Pfizer Drug Wins European Approval appeared first on MedCity News.
Expert insights. Personalized for you.
144 
Let's personalize your content